Global Health Ltd approves 20,000 ESOPs for one employee
Global Health Limited's Nomination and Remuneration Committee granted 20,000 ESOPs to a single employee on July 30, 2026, under the GHL LTIP 2024 Plan. The options have an exercise price of ₹1,147 and a maximum vesting period of five years. This initiative aims to align employee interests with long-term corporate growth.
*this image is generated using AI for illustrative purposes only.
The Nomination and Remuneration Committee of global health approved the grant of 20,000 Employee Stock Options (ESOPs) to one employee on July 30, 2026. The grant was made under Part A of the Global Health Limited Employees Long Term Share Based Incentive Plan 2024, known as the GHL LTIP 2024 Plan. This move aligns with the company’s strategy to attract, retain, and motivate key talent by linking employee rewards to corporate growth and profitability.
The committee meeting commenced at 11:00 A.M. and concluded at 11:35 A.M. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rahul Ranjan, Company Secretary & Compliance Officer, signed the intimation submitted to the Bombay Stock Exchange and the National Stock Exchange of India Limited.
Grant Details
The specific terms of the ESOP grant are outlined below:
| Particular | Details |
|---|---|
| Number of Options Granted | 20,000 |
| Exercise Price | ₹1,147 per option |
| Face Value of Equity Share | ₹2 per share |
| Eligible Employees | One employee |
| Vesting Period | Maximum of 5 years from the date of grant |
| Exercise Window | Within 3 years from the date of vesting of the last instalment |
Each option granted will result in the allotment of one equity share of ₹2 face value upon exercise. The scheme is compliant with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Strategic Context
The GHL LTIP 2024 Plan is designed to reward employees for their association, dedication, and contribution to the company’s goals. Management views the ESOP scheme as a long-term incentive tool that enables employees to become co-owners and create wealth through ownership. The vesting schedule and conditions are detailed in the individual grant letters issued to the recipient.
No options have been vested, exercised, or lapsed at this stage. The diluted earnings per share impact has not been calculated as no exercise has occurred.
Historical Stock Returns for Global Health
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.21% | +4.60% | +8.50% | +36.89% | +6.32% | +240.86% |
How might the vesting of these 20,000 ESOPs impact Global Health's diluted earnings per share (EPS) over the next five years?
What specific performance metrics or corporate milestones are likely tied to the vesting conditions for this key employee?
Will Global Health announce further ESOP grants under the GHL LTIP 2024 Plan to other executives in the upcoming quarters?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
